Transfusion medicine, in one place
All 18 chapters of our transfusion medicine study resource are now integrated into CP Board Review, alongside Henry and Tietz guides, flashcards, quizzes, and linked terminology.
Explore the learning updatesLaboratory medicine · Physician-founded
We build AI-assisted laboratory interpretation tools, report-writing support, and clinical pathology learning resources for physicians.
From focused practice to physician-reviewed workflows, our work begins with the questions clinicians face every day.
Free learning website available in Traditional Chinese.
Company update · October 11–14, 2026
Recent work brings transfusion medicine into our free learning platform, expands textbook and examination resources, and adds local image tools to our internal AI workspace.
All 18 chapters of our transfusion medicine study resource are now integrated into CP Board Review, alongside Henry and Tietz guides, flashcards, quizzes, and linked terminology.
Explore the learning updatesStrata drafted the Tietz liver disease chapter in our first local-AI chapter addition. The founder reports a substantial time investment and repeated attempts. A separate source review then corrected formulas, units, interpretation, and quiz answers before the revised version was published.
Read about the milestone and reviewOur local assistant can call a separate Qwen2.5-VL model to inspect images and crops, then use those observations in its answer. The workspace now includes model load/unload controls and measured vision-model text generation speed.
Explore the internal workspaceThe founder has added Grok and Manus to the AI team plan: Grok Premium for one month and Manus Pro for three months. Activation dates and project assignments are pending confirmation.
Meet the new AI assistantsOur name, our purpose
SIMU honors Si Mu, the literary name of Dr. Tu Tsung-ming and a personal family inspiration for our founder. CP brings together the clinical pathologist's perspective and the pursuit of meaningful value. AI Assist DX expresses our focus on AI-assisted interpretation.
We aim to contribute through accessible learning and carefully developed tools for medical professionals.
Read our company storyWe serve laboratory physicians, health check reporting teams, and medical professionals studying clinical pathology. Each product has a clearly stated development stage.
CZE immunosubtraction triage research to prioritize cases for detailed physician review. Development focuses on signal features and batch drift.
Explore the research prototypeSearchable phrases and structured comments for physician-reviewed health check reports. Patient-facing explanations use Traditional Chinese.
Explore reporting supportClinical pathology board preparation alongside stepwise medicine and surgery cases, viva practice, flashcards, and self-assessment. Both learning websites are free and use Traditional Chinese.
Physician-founded
Founded by Ken-Hao Hsu, MD, DVM, a resident in clinical pathology.
Meet the founderFounder-directed AI workforce: Claude, Codex, Kimi K3, Gemini (Antigravity), Qianwen, and local AI helper Strata / Qwen 3.8 Flash Next.
View our AI organizationBeyond the laboratory
Our development portfolio also includes Google-connected task and planning apps for web, Windows desktop, and Android, with Codex-assisted and Claude-assisted versions reported by the founder.
Explore the checked desktop and Android features, including calendar and task management, daily work files, and desktop weekly reviews.
Explore our productivity appsWe will continue providing free clinical pathology learning resources, including CP Board Review, Oxford Case Learning, and future reviewed educational additions.
Our free education commitmentWe plan to explore institutional software licensing and associated deployment and maintenance. Trial participation, measurable benefits, pricing, and willingness to pay remain unconfirmed.
Our planned business directionWork with us
Discuss laboratory reporting needs, educational collaboration, or research evaluation with our founder.
Contact the company